Research & Clinical Notes
Evidence-led articles on the botanical actives we use — written and reviewed by Ts. Ng Kuak Ping, FIFST. Citations from peer-reviewed human trials only.
Metabolic Health · Cardiotheca / Metatheca
Bergamot and Cholesterol — What the 2024 Clinical Evidence Actually Shows
The November 2024 four-month placebo-controlled RCT in detail: −8.8% total cholesterol, −11.5% LDL, +5.5% HDL trend at 150 mg/day standardized flavonoids. How Citrus bergamia compares to berberine, who should not take it, and what a “standardized extract” assay actually requires.
Read article →More evidence reviews are added as new clinical data publishes. Each article cites only peer-reviewed human trials.